MCA stability tool
Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.
Mirtazapine, 0 in your list
Mirtazapine 2mg capsules
No stability information
Stability notes for Mirtazapine 2mg capsules
There are no stability notes for this medicine.
Supplier
Mirtazapine 4mg capsules
No stability information
Stability notes for Mirtazapine 4mg capsules
There are no stability notes for this medicine.
Supplier
Mirtazapine 15mg orodispersible tablets
Incompatible
Stability notes for Mirtazapine 15mg orodispersible tablets
Formulation not suitable for use in MCAs. Very moisture sensitive medicine. Protect from light. No stability data in MCAs available.
Provenance
This recommendation is based on the products mirtazapine 15mg, 30mg and 45mg orodispersible tablets (Accord Healthcare Limited) and mirtazapine 15mg, 30mg and 45mg orodispersible tablets (Krka UK Ltd).
Suppliers (9) of Mirtazapine 15mg orodispersible tablets
Mirtazapine 15mg tablets
Use with caution
Stability notes for Mirtazapine 15mg tablets
Protect from moisture. Manufacturer recommends storing in original container. No stability data in MCAs available Anecdotal reports of use in MCAs for up to 7 days (low quality evidence)
Provenance
This recommendation is based on the products mirtazapine 15mg film-coated tablets (Accord Healthcare Limited) and mirtazapine 15mg film-coated tablets (Amarox Limited).
Suppliers (15) of Mirtazapine 15mg tablets
Mirtazapine 30mg orodispersible tablets
Incompatible
Stability notes for Mirtazapine 30mg orodispersible tablets
Formulation not suitable for use in MCAs. Very moisture sensitive medicine. Protect from light. No stability data in MCAs available.
Provenance
This recommendation is based on the products mirtazapine 15mg, 30mg and 45mg orodispersible tablets (Accord Healthcare Limited) and mirtazapine 15mg, 30mg and 45mg orodispersible tablets (Krka UK Ltd).
Suppliers (8) of Mirtazapine 30mg orodispersible tablets
Mirtazapine 30mg tablets
Use with caution
Stability notes for Mirtazapine 30mg tablets
Protect from moisture. Manufacturer recommends storing in original container. No stability data in MCAs available Anecdotal reports of use in MCAs for up to 7 days (low quality evidence)
Provenance
This recommendation is based on the products mirtazapine 30mg film-coated tablets (Accord Healthcare Limited) and mirtazapine 30mg film-coated tablets (Amarox Limited).
Suppliers (20) of Mirtazapine 30mg tablets
Mirtazapine 45mg orodispersible tablets
Incompatible
Stability notes for Mirtazapine 45mg orodispersible tablets
Formulation not suitable for use in MCAs. Very moisture sensitive medicine. Protect from light. No stability data in MCAs available.
Provenance
This recommendation is based on the products mirtazapine 45mg orodispersible tablets (Accord Healthcare Limited) and mirtazapine 45mg orodispersible tablets (Krka UK Ltd).
Suppliers (8) of Mirtazapine 45mg orodispersible tablets
Mirtazapine 45mg tablets
Use with caution
Stability notes for Mirtazapine 45mg tablets
Protect from moisture. Manufacturer recommends storing in original container. No stability data in MCAs available Anecdotal reports of use in MCAs for up to 7 days (low quality evidence).
Provenance
This recommendation is based on the products mirtazapine 45mg film-coated tablets (Accord Healthcare Limited) and mirtazapine 45mg film-coated tablets (Amarox Limited).